What Does OXFORD IMMUNOTEC GLOBAL PLC Do?

Total employees1
HeadquartersAbingdon
FoundedN/A

Oxford Immunotec Global PLC was a global, commercial-stage diagnostics company focused on developing and commercializing proprietary T-cell measurement technology for the ELISPOT platform. Its flagship product, the T-SPOT®.TB test, is a globally recognized ELISPOT-based assay for diagnosing latent tuberculosis infection. Founded in 2002 as a spin-out from the University of Oxford, the company dedicated itself to advancing immunology-based diagnostics. In March 2021, Oxford Immunotec was acquired by PerkinElmer, Inc. Subsequently, in May 2023, PerkinElmer's life sciences and diagnostics businesses, including the operations and technologies of Oxford Immunotec, were divested and rebranded as Revvity, Inc. Oxford Immunotec's legacy of innovation in T-cell diagnostics continues within Revvity, aiming to improve patient care through advanced diagnostic tools that assess immune function.

Where Is OXFORD IMMUNOTEC GLOBAL PLC's Headquarters?

HQ Function

Serves as a central hub for research and development, manufacturing, and administrative operations for Oxford Immunotec's diagnostic products, particularly the T-SPOT.TB test, now under Revvity's portfolio.

Notable Features:

Located within Milton Park, one of Europe's largest science, technology, and business communities, offering modern laboratory and office facilities designed for biotech innovation and collaboration.

Work Culture:

Historically fostered a collaborative and innovative environment focused on scientific excellence, quality, and a commitment to improving global health. As part of Revvity, it contributes to a broader culture dedicated to impacting human health through scientific discovery, advanced diagnostics, and a passion for results.

HQ Significance:

The Abingdon site remains crucial for the global supply, quality control, and ongoing development of the T-SPOT.TB test. It represents a key center of expertise in T-cell diagnostics and ELISPOT technology within Revvity.

Values Reflected in HQ: The facility and its operations reflect values of innovation, scientific rigor, quality manufacturing, and a commitment to addressing significant global health challenges, such as tuberculosis.

Location:

Oxford Immunotec's technologies, now part of Revvity, have a significant global footprint. Revvity supports the worldwide distribution and use of the T-SPOT.TB test and other diagnostic solutions through direct operations, dedicated teams, and strategic partnerships across North America, Europe, Asia, and other key international markets. Global functions managed by Revvity include sales and marketing, customer and technical support, manufacturing and supply chain, research and development, and regulatory affairs to ensure these diagnostic solutions meet diverse international standards and effectively reach patients and healthcare providers globally.

Street Address:

94C Innovation Drive, Milton Park

City:

Abingdon

State/Province:

Oxfordshire

Country:

United Kingdom

Where Else Does OXFORD IMMUNOTEC GLOBAL PLC Operate Around the World?

Marlborough, Massachusetts, USA

Address: 500 Nickerson Road, Suite 200, Marlborough, MA 01752, USA (historical address, operations now integrated with Revvity's US sites)

To facilitate access to and support for Oxford Immunotec's diagnostic products in the United States and Canada. This role continues under Revvity to serve healthcare providers, public health organizations, and patients in the region.

Singapore

Address: Revvity Singapore Pte. Ltd. (Specific Oxford Immunotec address integrated)

To expand access to advanced TB diagnostics and support healthcare systems in the APAC region in managing tuberculosis and other immune-related conditions.

Buying Intent Signals for OXFORD IMMUNOTEC GLOBAL PLC

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading OXFORD IMMUNOTEC GLOBAL PLC? Meet the Executive Team

As of April 2025, OXFORD IMMUNOTEC GLOBAL PLC' leadership includes:

Dr. Peter Wrighton-Smith - Founder and Former Chief Executive Officer
Richard Koch - Former Chief Financial Officer (at time of acquisition)
Dr. Andrew Noble - Former Chief Commercial Officer (at time of acquisition)
Dr. K G. Julian Hodgson - Former Chief Operating Officer

Who's Investing in OXFORD IMMUNOTEC GLOBAL PLC?

OXFORD IMMUNOTEC GLOBAL PLC has been backed by several prominent investors over the years, including:

PerkinElmer, Inc. (Acquirer in 2021, now part of Revvity)
Clarus Ventures (Pre-acquisition)
New Leaf Venture Partners (Pre-acquisition)
Kaiser Permanente Ventures (Pre-acquisition)
DFJ Esprit (Pre-acquisition)
Wellington Partners (Pre-acquisition)
Invesco Perpetual (Pre-acquisition)

What Leadership Changes Has OXFORD IMMUNOTEC GLOBAL PLC Seen Recently?

Hire0
Exits0

Following its acquisition by PerkinElmer in 2021 and the subsequent formation of Revvity in 2023, executive roles specific to the former 'Oxford Immunotec Global PLC' entity have been integrated into the broader Revvity leadership structure. Distinct executive news for 'Oxford Immunotec' as a standalone brand is generally reflected in appointments or changes within Revvity's diagnostics or relevant regional leadership teams. No specific 'Oxford Immunotec Global PLC' branded executive hires or exits have been announced in the last 12 months under that distinct name.

What Technology (Tech Stack) Is Used byOXFORD IMMUNOTEC GLOBAL PLC?

Discover the tools OXFORD IMMUNOTEC GLOBAL PLC uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

OXFORD IMMUNOTEC GLOBAL PLC Email Formats and Examples

Personnel associated with Oxford Immunotec's products and operations, now part of Revvity, typically use Revvity's corporate email format. Common formats include [first].[last]@revvity.com or [first_initial][last]@revvity.com. Historically, Oxford Immunotec likely used similar structures with its own domain (e.g., @oxfordimmunotec.com).

[first].[last]@revvity.com or [first_initial][last]@revvity.com

Format

john.doe@revvity.com or jdoe@revvity.com

Example

80%

Success rate

What's the Latest News About OXFORD IMMUNOTEC GLOBAL PLC?

Revvity Official WebsiteMay 9, 2023

Revvity Launches as a Leading Life Sciences and Diagnostics Company, Integrating Oxford Immunotec's Technologies

Revvity Inc. officially launched, following the divestiture of PerkinElmer's applied, food and enterprise services businesses. Revvity combines the former life sciences and diagnostics businesses, including the advanced T-cell diagnostic technologies developed by Oxford Immunotec, to focus on improving human health through scientific innovation and a mission to expand the boundaries of human potential through science....more

PerkinElmer (via Business Wire)March 16, 2021

PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC

PerkinElmer, Inc. announced it had successfully completed its acquisition of Oxford Immunotec Global PLC. Oxford Immunotec was recognized as a global leader in T-cell immunology, with its T-SPOT.TB test being a leading FDA-approved and CE-marked blood test for tuberculosis. The acquisition aimed to expand PerkinElmer's portfolio of infectious disease testing solutions....more

The Wales Cancer Biobank (WCB) via Revvity NewsFebruary 23, 2024

Wales Cancer Biobank Deploys Revvity’s T-SPOT Discovery SARS-CoV-2 Kit (Technology originating from Oxford Immunotec) to Study T Cell Response to COVID-19

The Wales Cancer Biobank (WCB) is utilizing Revvity's T-SPOT Discovery SARS-CoV-2 kit for research into the T cell immune response to COVID-19 infection and vaccination in cancer patients. This technology, based on the T-SPOT platform pioneered by Oxford Immunotec, aids in understanding cellular immunity....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including OXFORD IMMUNOTEC GLOBAL PLC, are just a search away.